Innovative Medicines for Tuberculosis
2 clinical trials · Sponsor
◉ Watch Innovative Medicines for Tuberculosis
| Record | Firm | Date |
|---|---|---|
| Study to Evaluate the Safety, Tolerability and Pharmacokinetics of PBTZ169 in Multiple Dosing (NCT03776500) | Innovative Medicines for Tuberculosis | 2019-02-21 |
| Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Ex-vivo Antitubercular Activity of PBTZ169 Formulation (NCT03423030) | Innovative Medicines for Tuberculosis | 2017-12-05 |
Track Innovative Medicines for Tuberculosis automatically
Every clearance here is in the API, with alerts when new ones post.